Deutsche Bank Ag\ Inhibrx, Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

A detailed history of Deutsche Bank Ag\ transactions in Inhibrx, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 54,804 shares of INBX stock, worth $776,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,804

Previous 16,308 236.06%

Holding current value

$776,572

Previous $619,000 209.37%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$32.76 - $39.56 $1.26 Million - $1.52 Million	38,496 Added 236.06%	54,804 $1.92 Million
Q4 2023 Feb 14, 2024	BUY	$14.5 - $38.0 $1,218 - $3,192	84 Added 0.52%	16,308 $619,000
Q3 2023 Nov 09, 2023	BUY	$15.75 - $26.31 $33,957 - $56,724	2,156 Added 15.33%	16,224 $297,000
Q2 2023 Aug 14, 2023	SELL	$16.96 - $27.82 $165,784 - $271,940	-9,775 Reduced 41.0%	14,068 $365,000
Q1 2023 May 15, 2023	BUY	$18.45 - $27.14 $110,072 - $161,917	5,966 Added 33.37%	23,843 $449,000

Q4 2022 Feb 13, 2023	BUY	$20.18 - $33.33 $80,518 - $132,986	3,990 Added 28.73%	17,877 $440,000
Q3 2022 Nov 14, 2022	SELL	$11.58 - $24.73 $7,538 - $16,099	-651 Reduced 4.48%	13,887 $250,000
Q2 2022 Aug 11, 2022	SELL	$8.52 - $25.26 $471,011 - $1.4 Million	-55,283 Reduced 79.18%	14,538 $165,000
Q1 2022 May 13, 2022	SELL	$19.89 - $43.18 $70,171 - $152,339	-3,528 Reduced 4.81%	69,821 $1.56 Million
Q4 2021 Feb 11, 2022	BUY	$26.75 - $46.02 $74,070 - $127,429	2,769 Added 3.92%	73,349 $3.2 Million
Q3 2021 Nov 04, 2021	SELL	$25.18 - $37.81 $13,093 - $19,661	-520 Reduced 0.73%	70,580 $2.35 Million
Q2 2021 Aug 11, 2021	BUY	$14.69 - $27.52 $964,545 - $1.81 Million	65,660 Added 1206.99%	71,100 $1.96 Million
Q1 2021 May 13, 2021	SELL	$16.27 - $41.26 $4,246 - $10,768	-261 Reduced 4.58%	5,440 $109,000
Q4 2020 Feb 16, 2021	BUY	$15.96 - $50.0 $90,987 - $285,050	5,701 New	5,701 $188,000

Others Institutions Holding INBX

# of Institutions

132

Shares Held

35.5M

Call Options Held

64.8K

Put Options Held

91.3K

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $553M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account